[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 48, "title": "CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 491961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 66, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 415167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 59, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 65, "title": "Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.3735, "open": 0.3767, "dayLow": 0.352, "dayHigh": 0.4, "regularMarketPreviousClose": 0.3735, "regularMarketOpen": 0.3767, "regularMarketDayLow": 0.352, "regularMarketDayHigh": 0.4, "beta": -1.091, "forwardPE": -0.15150215, "volume": 292550, "regularMarketVolume": 292550, "averageVolume": 544963, "averageVolume10days": 555020, "averageDailyVolume10Day": 555020, "bid": 0.2688, "ask": 0.4577, "bidSize": 200, "askSize": 200, "marketCap": 3691638, "fiftyTwoWeekLow": 0.284, "fiftyTwoWeekHigh": 15.6, "fiftyDayAverage": 0.57112, "twoHundredDayAverage": 2.99407, "currency": "USD", "enterpriseValue": 1443386, "floatShares": 5981237, "sharesOutstanding": 10457900, "sharesShort": 199047, "sharesShortPriorMonth": 204401, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.019, "heldPercentInsiders": 0.12303001, "heldPercentInstitutions": 0.03867, "shortRatio": 0.19, "shortPercentOfFloat": 0.0217, "impliedSharesOutstanding": 10457900, "bookValue": 0.642, "priceToBook": 0.5498442, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -22502536, "trailingEps": -19.52, "forwardEps": -2.33, "lastSplitFactor": "1:20", "lastSplitDate": 1701302400, "enterpriseToEbitda": -0.068, "52WeekChange": -0.96612287, "SandP52WeekChange": 0.18961596, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CING", "underlyingSymbol": "CING", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "firstTradeDateEpochUtc": 1638973800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "bf898f9d-c1c1-3f31-9c96-a5b2c0f73dcd", "messageBoardId": "finmb_1674914781", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.353, "targetHighPrice": 20.0, "targetLowPrice": 8.0, "targetMeanPrice": 14.0, "targetMedianPrice": 14.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 1113830, "totalCashPerShare": 0.184, "ebitda": -21211522, "totalDebt": 422809, "quickRatio": 0.524, "currentRatio": 1.214, "debtToEquity": 13.147, "returnOnAssets": -2.15855, "returnOnEquity": -13.647281, "freeCashflow": -11954895, "operatingCashflow": -20204442, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-29"}]